Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement

BMC Medical Ethics

Volumn 10, Issue 1, 2009, Pages

  Forlini, Cynthia ^a,b   Racine, Eric ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR;

ARTICLE; BIOETHICS; COGNITION; DATA BASE; DRUG ABUSE; EDUCATION; ETHICS; INFORMATION; INSTITUTIONAL CARE; LAW; LEGAL ASPECT; MEDICINE; PHARMACEUTICAL CARE; PHYSICAL PERFORMANCE; PREVALENCE; PUBLIC HEALTH; RISK; SOCIAL ASPECT; SOCIETY; CONFLICT; DRUG EFFECT; HUMAN; METHODOLOGY; PRESCRIPTION; PUBLIC OPINION; REVIEW; STANDARD;

BIOETHICAL ISSUES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DISSENT AND DISPUTES; DOPAMINE UPTAKE INHIBITORS; DRUG PRESCRIPTIONS; HUMANS; METHYLPHENIDATE; PUBLIC OPINION; RESEARCH DESIGN;

EID: 68249162523     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-10-9     Document Type: Article

References (71)

1. British Medical Association, Boosting your brainpower: ethical aspects of cognitive enhancement London; BMA 2007
2. Canadian Centre on Substance Abuse, Prescription drug abuse FAQs Ottawa; CCSA 2007
3. Neurocognitive enhancement: what can we do and what should we do? MJ Farah J Illes R Cook-Deegan H Gardner E Kandel P King E Parens B Sahakian PR Wolpe, Nature Reviews Neuroscience 2004 5 5 421 425 10.1038/nrn1390 15100724
4. Lifestyle drugs: pharmacology and the social agenda. R Flower, Trends in Pharmacological Science 2004 25 4 182 185 10.1016/j.tips.2004.02.006 (Pubitemid 38519908)
5. Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Ethical blindspots in current debates. E Racine C Forlini, Neuroethics 2008 http://www.springerlink.com/content/u22547313857t607/fulltext.pdf
6. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. TE Wilens LA Adler J Adams S Sgambati J Rotrosen R Sawtelle L Utzinger S Fusillo, Journal of the American Academy of Child and Adolescent Psychiatry 2008 47 1 21 31 10.1097/chi.0b013e31815a56f1
7. When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. JM Appel, Journal of Medical Ethics 2008 34 8 616 618 10.1136/jme.2007.022723 18667652
8. The Neurocognitive Enhancement of Surgeons: an ethical perspective. OJ Warren DR Leff T Athanasiou C Kennard A Darzi, J Surg Res 2008 18394651
9. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. ML Wolraich CJ Wibbelsman TE Brown SW Evans EM Gotlieb JR Knight EC Ross HH Shubiner EH Wender T Wilens, Pediatrics 2005 115 6 1734 1746 10.1542/peds.2004-1959 15930238 (Pubitemid 43843185)
10. Cognitive enhancement raises ethical concerns. Academics urge pre-emptive debate on neurotechnologies. J Butcher, Lancet 2003 362 9378 132 133 10.1016/S0140-6736(03)13897-4 12867135 (Pubitemid 36831027)
11. Abuse of prescription drugs and the risk of addiction. WM Compton ND Volkow, Drug and Alcohol Dependence 2006 83 S4 7 10.1016/j.drugalcdep.2005.10. 020
12. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. SH Kollins EK MacDonald CR Rush, Pharmacology, Biochemistry and Behavior 2001 68 3 611 627 10.1016/S0091-3057(01)00464-6 (Pubitemid 32452420)
13. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. ND Volkow YS Ding JS Fowler GJ Wang J Logan JS Gatley S Dewey C Ashby J Liebermann R Hitzemann AP Wolf, Archives of General Psychiatry 1995 52 6 456 463 7771915
14. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. ND Volkow JM Swanson, American Journal of Psychiatry 2003 160 11 1909 1918 10.1176/appi.ajp.160.11.1909 14594733 (Pubitemid 39619623)
15. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. LH Diller, Hastings Centre Report 1996 26 2 12 18 10.2307/3528571
16. Beyond polemics: science and ethics of ADHD. I Singh, Nature Reviews Neuroscience 2008 9 12 957 964 10.1038/nrn2514 19020513
17. Students taking danger drug to help with exams. K Bayer, The Express 2004
18. Abuse hits students looking for an exam kick. J Laurance, The Independent 2003
19. 'Kiddie speed' for exam boost. J Lawrence, Sunday Mail 2004
20. Want to be clever? Don't take 'smart drugs'. N O'Regan, Irish Independent 2005
21. Students turn to smart drugs for exam help. S Ross, The Scotsman 2006
22. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. SE McCabe JR Knight CJ Teter H Wechsler, Addiction 2005 100 1 96 106 10.1111/j.1360-0443.2005.00944.x 15598197
23. Illicit use of psychostimulants among college students: a preliminary study. K Graff Low AE Gendaszek, Psychology, Health & Medicine 2002 7 3 283 287 10.1080/13548500220139386 (Pubitemid 34885841)
24. Portrayal of lobotomy in the popular press: 1935-1960. GJ Diefenbach D Diefenbach A Baumeister M West, Journal of the History of the Neurosciences 1999 8 1 60 69 10.1076/jhin.8.1.60.1766 11624138 (Pubitemid 29394830)
25. "Currents of hope": neurostimulation techniques in U.S. and U.K. print media. E Racine S Waldman N Palmour D Risse J Illes, Cambridge Quarterly of Healthcare Ethics 2007 16 3 312 316 10.1017/S0963180107070351 17695623
26. The neural bases of cooperation and competition: an fMRI investigation. J Decety PL Jackson JA Sommerville T Chaminade AN Meltzoff, NeuroImage 2004 23 2 744 751 10.1016/j.neuroimage.2004.05.025 15488424 (Pubitemid 39370625)
27. How to (or not to) communicate science. SPR Rose, Biochemical Society Transactions 2003 31 Part 2 307 312 10.1042/BST0310307 12653626 (Pubitemid 36520664)
28. Brain Imaging: a decade of coverage in the print media. E Racine O Bar-Ilan J Illes, Science Communication 2006 28 1 122 142 17330151 10.1177/1075547006291990 (Pubitemid 44117868)
29. Student perceptions of methylphenidate abuse at a public liberal arts college. Q Babcock T Byrne, Journal of American College Health 2000 49 3 143 145 11125642
30. fMRI in the public eye. E Racine O Bar-Ilan J Illes, Nature Reviews Neuroscience 2005 6 2 159 164 15685221 10.1038/nrn1609
31. Hyped biomedical science or uncritical reporting? Press coverage of genomics (1992-2001) in Québec. E Racine I Gareau H Doucet D Laudy G Jobin P Schraedley-Desmond, Social Science & Medicine 2006 62 5 1278 1290 10.1016/j.socscimed.2005.07.024 (Pubitemid 43129590)
32. KA Neuendorf, The Content Analysis Guidebook Thousand Oaks: Sage Publications 2002
33. How Ritalin became poor man's cocaine; warnings over increasing adult abuse of children's drug. L Adams, The Herald 2005
34. Ritalin grows as 'cramming drug' at U.S. colleges; medicine can have serious side effects. J Diaz, The Seattle Times 2001
35. 'Smart pills' are on the rise. But is taking them wise? J Garreau, The Washington Post 2006
36. Who needs a dealer.when you have a doctor? New Yorkers are just saying yes to prescription abuse. J Lite, Daily News 2006 16648960
37. An espresso in the morning is just so last year. S Phillips, The Times Higher Education Supplement 2006
38. Colleges eye ways to curb Ritalin abuse. A Reinink, Denver Post 2001
39. The difference between steroids and Ritalin is. K Zernike, The New York Times 2005 15838968
40. Feeling 'better than well'. W Hall, EMBO Reports 2004 5 12 1105 1109 15577921 10.1038/sj.embor.7400303 (Pubitemid 40103599)
41. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. CJ Teter SE McCabe K LaGrange JA Cranford CJ Boyd, Pharmacotherapy 2006 26 10 1501 1510 16999660 10.1592/phco.26.10.1501 (Pubitemid 44521735)
42. Ritalin, Product information. Novartis, East Hanover, New Jersey, USA: Novartis Pharmaceuticals 2007
43. Ritalin LA, Product information. Novartis, North Ryde, New South Wales, Australia: Novartis Pharmaceuticals 2008
44. Ritalin, Product information. Novartis, Frimbley, Camberly, Surrey, UK: Novartis Pharmaceuticals UK 2007
45. Ritalin, Product information. Novartis, Dorval, Quebec, Canada: Novartis Pharmaceuticals Canada 2007
46. New Campus High: Illicit Prescription Drugs. P Zeilbauer, The New York Times 2000
47. Study drugs draw concern. M Khan, The Miami Herald 2003
48. Cognition-enhancing drugs. MJ Mehlman, The Milbank Quarterly 2004 82 3 483 506 15330974
49. Characteristics of methylphenidate misuse in a university student sample. SP Barrett C Darredeau LE Bordy RO Pihl, Can J Psychiatry 2005 50 8 457 461 16127963
50. Students abusing ADHD drugs: prescription pills easy to get, youths, health workers say. S Hupp, The Indianapolis Star 2006
51. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. CJ Teter SE McCabe JA Cranford CJ Boyd SK Guthrie, Journal of American College Health 2005 53 6 253 262 10.3200/JACH.53.6.253-262 15900989
52. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. BP White KA Becker-Blease K Grace-Bishop, Journal of American College Health 2006 54 5 261 268 10.3200/JACH.54.5.261-268 16539218
53. Enhancing cognition in the intellectually intact. PJ Whitehouse E Juengst M Mehlman TH Murray, Hastings Centre Report 1997 27 3 14 22 10.2307/3528662
54. A new form of drug abuse. Anonymous, The Plain Dealer 2004
55. One danger of biomedical enhancements. A Rajczi, Bioethics 2008 22 6 328 336 10.1111/j.1467-8519.2008.00637.x 18522592
56. Cognition enhancers between treating and doping the mind. C Lanni SC Lenzken A Pascale I Del Vecchio M Racchi F Pistoia S Govoni, Pharmacological Research 2008 57 3 196 213 10.1016/j.phrs.2008.02.004 18353672
57. Effects of methylphenidate on spatial working memory and planning in healthy young adults. R Elliott BJ Sahakian K Matthews A Bannerjea J Rimmer TW Robbins, Psychopharmacology 1997 131 2 196 206 10.1007/s002130050284 9201809 (Pubitemid 27261609)
58. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. MA Mehta AM Owen BJ Sahakian N Mavaddat JD Pickard TW Robbins, Journal of Neuroscience 2000 20 6 RC65 10704519
59. Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. DM Barch CS Carter, Schizophrenia Research 2005 77 1 43 58 10.1016/j.schres.2004.12.019 16005384 (Pubitemid 40957060)
60. Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults. CL Bray KS Cahill JT Oshier CS Peden DW Theriaque TR Flotte PW Stacpoole, Journal of Investigational Medicine 2004 52 3 192 201 10.2310/6650.2004.02053
61. When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study. MJ Farah C Haimm G Sankoorikal A Chatterjee, Psychopharmacology 2008 202 3 541 547 10.1007/s00213-008-1369-3 19011838
62. Ritalin. Canadian Pharmacists Association, e-Compendium of Pharmaceuticals and Specialties. Toronto 39 2008
63. Poll results: look who's doping. B Maher, Nature 2008 452 7188 674 675 10.1038/452674a 18401370
64. Modafinil in the media: metaphors, medicalisation and the body. CM Coveney B Nerlich P Martin, Social Science & Medicine 2008 68 3 487 495 10.1016/j.socscimed.2008.11.016
65. P Kramer, Listening to Prozac London: Penguin Books 1997
66. Towards responsible use of cognitive-enhancing drugs by the healthy. H Greely B Sahakian J Harris RC Kessler M Gazzaniga P Campbell MJ Farah, Nature 2008 456 7223 702 705 10.1038/456702a 19060880
67. Reporting guidelines: drugs and drug addiction. Australian Press Council, General Press Release No 246 (ii) 2001
68. New developments in the illegal provision of growth hormone for "anti-aging" and bodybuilding. SJ Olshansky TT Perls, Journal of the American Medical Association 2008 299 23 2792 2794 10.1001/jama.299.23.2792 18560007 (Pubitemid 351846855)
69. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. A Chatterjee, Neurology 2004 63 6 968 974 15452285
70. National Institute on Drug Abuse, Prescription drugs: abuse and addiction Bethesda; NIDA 2005
71. Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population. LS Bergstrom N Lynoe, Scandinavian Journal of Public Health 2008 36 5 532 537 10.1177/1403494807087558 18635734 (Pubitemid 352044557)